 Karyopharm Therapeutics, Inc. NASDAQ:KPTI Q2 2022 Results Conference Call August 4, 2022 8:00 AM ET Company Participants Elhan Webb - SVP, IR Richard Paulson - President, CEO Director Sohanya Cheng - EVP Chief Commercial Officer Mike Mason - EVP, CFO Treasurer Reshma Rangwala - Chief Medical Officer Conference Call Participants Kevin Strang - Jefferies Peter Lawson - Barclays Mike Ulz - Morgan Stanley Colleen Kusy - Baird Eric Joseph - JP Morgan Ed White - H.C Faisal Khurshid - SVB Securities Operator Good morning, and welcome to the Karyopharm Therapeutics Q2 22 Earnings Conference Call. Operator Instructions Please note, this event is being recorded. 